Genetic Cancer Risk Group


Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis
Ballinger, M. L.; Best, A.; Mai, P. L.; Khincha, P. P.; Loud, J. T.; Peters, J. A.; Achatz, M. I.; Chojniak, R.; Balieiro da Costa, A.; Santiago, K. M.; Garber, J.; O'Neill, A. F.; Eeles, R. A.; Evans, D. G.; Bleiker, E.; Sonke, G. S.; Ruijs, M.; Loo, C.; Schiffman, J.; Naumer, A.; Kohlmann, W.; Strong, L. C.; Bojadzieva, J.; Malkin, D.; Rednam, S. P.; Stoffel, E. M.; Koeppe, E.; Weitzel, J. N.; Slavin, T. P.; Nehoray, B.; Robson, M.; Walsh, M.; Manelli, L.; Villani, A.; Thomas, D. M.; Savage, S. A.
JAMA Oncology 3(12):1634-1639, 2017
Penetrance of different cancer types in families with Li-Fraumeni syndrome: A validation study using multicenter cohort.
Shin, S. J.; Dodd-Eaton, E. B.; Peng, G.; Bojadzieva, J.; Chen, J.; Amos, C. I.; Frone, M. N.; Khincha, P. P.; Mai, P. L.; Savage, S. A.; Ballinger, M. L.; Thomas, D. M.; Yuan, Y.; Strong, L. C.; Wang, W.
CANCER RESEARCH 80(2):354-360, 2020
Recommended guidelines for validation, quality control, and reporting of TP53 variants in clinical practice
Leroy, B.; Ballinger, M. L.; Baran-Marszak, F.; Bond, G. L.; Braithwaite, A.; Concin, N.; Donehower, L. A.; El-Deiry, W. S.; Fenaux, P.; Gaidano, G.; Langerod, A.; Hellstrom-Lindberg, E.; Iggo, R.; Lehmann-Che, J.; Mai, P. L.; Malkin, D.; Moll, U. M.; Myers, J. N.; Nichols, K. E.; Pospisilova, S.; Ashton-Prolla, P.; Rossi, D.; Savage, S. A.; Strong, L. C.; Tonin, P. N.; Zeillinger, R.; Zenz, T.; Fraumeni, J. F., Jr.; Taschner, P. E.; Hainaut, P.; Soussi, T.
CANCER RESEARCH 77(6):1250-1260, 2017
Advanced cancer patient wnowledge of and attitudes towards tumor molecular profiling
Davies, G.; Butow, P.; Napier, C. E.; Bartley, N.; Juraskova, I.; Meiser, B.; Ballinger, M. L.; Thomas, D. M.; Schlub, T. E.; Best, M. C.; members of the PiGeOn, Project.
Translational Oncology 13(9):100799, 2020
Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients
Koster, R.; Panagiotou, O. A.; Wheeler, W. A.; Karlins, E.; Gastier-Foster, J. M.; Caminada de Toledo, S. R.; Petrilli, A. S.; Flanagan, A. M.; Tirabosco, R.; Andrulis, I. L.; Wunder, J. S.; Gokgoz, N.; Patino-Garcia, A.; Lecanda, F.; Serra, M.; Hattinger, C.; Picci, P.; Scotlandi, K.; Thomas, D. M.; Ballinger, M. L.; Gorlick, R.; Barkauskas, D. A.; Spector, L. G.; Tucker, M.; Belynda, D. H.; Yeager, M.; Hoover, R. N.; Wacholder, S.; Chanock, S. J.; Savage, S. A.; Mirabello, L.
Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson's disease
Reeve, A. K.; Grady, J. P.; Cosgrave, E. M.; Bennison, E.; Chen, C.; Hepplewhite, P. D.; Morris, C. M.
NPJ Parkinson's Disease 4:9, 2018
Monogenic and polygenic determinants of sarcoma risk: an international genetic study
Ballinger, M. L.; Goode, D. L.; Ray-Coquard, I.; James, P. A.; Mitchell, G.; Niedermayr, E.; Puri, A.; Schiffman, J. D.; Dite, G. S.; Cipponi, A.; Maki, R. G.; Brohl, A. S.; Myklebost, O.; Stratford, E. W.; Lorenz, S.; Ahn, S. M.; Ahn, J. H.; Kim, J. E.; Shanley, S.; Beshay, V.; Randall, R. L.; Judson, I.; Seddon, B.; Campbell, I. G.; Young, M. A.; Sarin, R.; Blay, J. Y.; O'Donoghue, S. I.; Thomas, D. M.; International Sarcoma Kindred, Study;
LANCET ONCOLOGY 17(9):1261-71, 2016
Simultaneous profiling of activity patterns in multiple neuronal subclasses
Parrish, R. R.; Grady, J.; Codadu, N. K.; Trevelyan, A. J.; Racca, C.
Surveillance in Germline TP53 Mutation Carriers Utilizing Whole-Body Magnetic Resonance Imaging
Ballinger, M. L.; Ferris, N. J.; Moodie, K.; Mitchell, G.; Shanley, S.; James, P. A.; Thomas, D. M.
JAMA Oncology 3(12):1735-1736, 2017
Who should access germline genome sequencing? A mixed methods study of patient views
Best, M. C.; Butow, P.; Jacobs, C.; Savard, J.; Biesecker, B.; Ballinger, M. L.; Bartley, N.; Davies, G.; Napier, C. E.; Smit, A. K.; Thomas, D. M.; Newson, A. J.; Members of the PiGeOn Project, .
CLINICAL GENETICS 97(2):329-337, 2020
Patient experience of uncertainty in cancer genomics: a systematic review
Bartley, N.; Napier, C.; Best, M.; Butow, P.
GENETICS IN MEDICINE 22(9):1450-1460, 2020
Advanced cancer patient preferences for receiving molecular profiling results
Best, M.; Butow, P.; Jacobs, C.; Juraskova, I.; Savard, J.; Meiser, B.; Goldstein, D.; Ballinger, M.; Bartley, N.; Napier, C.; Davies, G.; Thomas, D.; Tucker, K.; Schlub, T.; Newson, A. J.; PiGeOn Project, .
PSYCHO-ONCOLOGY 29(10):1533-1539, 2020
Cancer patients' views and understanding of genome sequencing: a qualitative study
Bartley, N.; Best, M.; Jacobs, C.; Juraskova, I.; Newson, A. J.; Savard, J.; Meiser, B.; Ballinger, M. L.; Thomas, D. M.; Biesecker, B.; Butow, P.
JOURNAL OF MEDICAL GENETICS 57(10):671-676, 2020
Assessment of the value of tumor variation profiling perceived by patients with cancer
Butow, P.; Davies, G.; Napier, C. E.; Schlub, T.; Best, M. C.; Bartley, N.; Juraskova, I.; Meiser, B.; Ballinger, M. L.; Biesecker, B.; Goldstein, D.; Thomas, D. M.; PiGeOn, Project
JAMA Network Open 3(5):e204721, 2020
Graphical user interface for simultaneous profiling of activity patterns in multiple neuronal subclasses
Parrish, R. R.; Grady, J.; Codadu, N. K.; Racca, C.; Trevelyan, A. J.
Data in Brief 20:226-233, 2018
Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?
McBride, K. A.; Ballinger, M. L.; Schlub, T. E.; Young, M. A.; Tattersall, M. H.; Kirk, J.; Eeles, R.; Killick, E.; Walker, L. G.; Shanley, S.; Thomas, D. M.; Mitchell, G.
Familial Cancer 16(3):423-432, 2017
Estimating TP53 mutation carrier probability in families with Li-Fraumeni syndrome using LFSPRO
Peng, G.; Bojadzieva, J.; Ballinger, M. L.; Li, J.; Blackford, A. L.; Mai, P. L.; Savage, S. A.; Thomas, D. M.; Strong, L. C.; Wang, W.
Translating genomic risk into an early detection strategy for sarcoma
Ballinger, M. L.; Pinese, M.; Thomas, D. M.